BioXcel Therapeutics, Inc.
BTAI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$30,911 | -$19,187 | -$7,254 | -$10,859 |
| Dep. & Amort. | $75 | $75 | $76 | $77 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,556 | $180 | $0 |
| Change in WC | -$1,596 | $2,405 | -$1,583 | -$3,555 |
| Other Non-Cash | $13,645 | $2,576 | -$3,462 | -$472 |
| Operating Cash Flow | -$18,787 | -$12,575 | -$12,043 | -$14,809 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$2,500 |
| Stock Issued | $37,548 | $140 | $14,006 | $6,822 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$16 | -$3 | -$804 | -$46 |
| Financing Cash Flow | $37,532 | $137 | $13,202 | $4,276 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $18,745 | -$12,438 | $1,159 | -$10,533 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $18,575 | $31,013 | $29,854 | $40,387 |
| End Cash | $37,320 | $18,575 | $31,013 | $29,854 |
| Free Cash Flow | -$18,787 | -$12,575 | -$12,043 | -$14,809 |